Agri-biotech company announces second close of capital raise
This second close brings in an additional AUD$8 million, following an initial first close of AUD$10 million completed in October 2025.
With both closes combined, Nbryo has now raised a total of AUD$18 million in this capital raising round.
Nbryo is developing next-generation solutions in bovine reproductive technologies. Its integrated IVF technology platform combines biotechnology with digital tools to deliver scalable, efficient, and high-quality outcomes for cattle producers worldwide.
Nbryo Chief Executive Officer Paul Niven said the round received further support from Tenacious Ventures and AgriZeroNZ, demonstrating ongoing confidence in Nbryo by subscribing again in this second close.
Mr Niven said their commitment, alongside new and returning investors, enabled Nbryo to meet its minimum AUD$8 million target for this second close, and achieve an overall total of AUD$18 million raised.
“We are delighted to welcome the Gates Foundation as a new equity investor in Nbryo. Their involvement opens doors and will help us deliver on our mission,” he said.
This second close strengthens Nbryo’s ability to execute its strategy, expand its proprietary IVF and embryo transfer technology platform, and accelerate the delivery of next generation solutions for cattle producers worldwide.“The company’s integrated approach, combining biotechnology with digital tools, continues to set new standards for efficiency, scalability, and genetic gain in the beef and dairy sectors,” Mr Niven said.
“Nbryo extends its sincere appreciation to all investors who participated in this second close, as well as those who contributed to the September close.
“The company also acknowledges the ongoing support from broader stakeholders, including employees, grant funders, commercial partners, and customers.
“Special thanks go to the Capital Raising team, the board, and the executive leadership whose dedication and expertise ensured the successful completion of this milestone.”
